- Our Work
- Agriculture and Food Security
- Democracy, Human Rights, and Governance
- Economic Growth and Trade
- Gender Equality and Women's Empowerment
- Global Health
- Working in Crises and Conflict
- Power Africa
- Dollars to Results
- WORK WITH US
USAID focuses on saving thousands of lives by supporting the Government of Ethiopia to strengthen treatment, detection, and referral services to combat Tuberculosis (TB) in Ethiopia. According to the 2014 WHO Global TB report, 22 high burden countries account for 80 percent of the global TB cases and Ethiopia has the tenth highest TB burden in the world. Ethiopia is also one of the 27 high MDR-TB burden countries. USAID resources improve and expand TB diagnostic and treatment services and screening in rural areas and among HIV positive individual, which make up to 13 percent of TB cases each year. USAID TB activities help increase the availability and demand for TB prevention, care and treatment services through improved national and regional level TB management and technical capacity; Expanding TB services to all health facilities to achieve universal directly observed treatment short course (DOTS) coverage; scale-up of management of multi-drug resistant TB (MDR-TB); enhanced TB/HIV collaborative services which focuses on provision of TB services for HIV infected people and HIV services for TB patients; strengthened health systems with a focus on improving TB medicine and commodity supplies, monitoring and evaluation of TB activities; and develop human resource capacity.
Achievements of USAID-funded TB control efforts include strengthened TB program capacity at national and regional levels including enhancing private sector involvement in TB case detection , treatment and referral; expanded TB laboratory microscopy and culture capacity; community TB care; and MDR-TB service expansion. From 2005 to 2014, USAID helped Ethiopia improve the treatment success rate from 79 percent to more than 90 percent, increase the case detection rate from 33 percent to 62, and lower TB mortality from 73 to 32 per 100,000 (2005 and 2014 WHO Global TB reports). Through USAID support, Ethiopia has started the treatment of more than 1,600 MDR-TB patients since 2009. Furthermore, USAID continues to support the establishment of MDR-TB centers at selected regional and zonal hospitals as well as centers of excellence for diagnosis and management of multi-drug resistant and extensively drug resistant TB at two hospitals in Addis Ababa.
Challenge TB: Provides support at a national and regional (Tigray and SNNP regions) levels and urban centers with a focus on urban poor, prisoners, migrant/mobile workers, pastoralists and miners (key populations) for TB treatment expansion and enhancement, TB/HIV collaboration, MDR-TB treatment and detection, health system strengthening, and program technical and management support.
Help Ethiopia Address Low TB Performance (HEAL TB): Improves TB detection and treatment in populous Amhara and Oromia regions by providing comprehensive tuberculosis program support at regional, zonal, woreda (district) and health facility levels as well as strengthening community level TB program support through the existing Health Extension Program
Private Health Sector Program (PHSP): Enhances the private public partnership in TB control program by networking selected private health facilities with public health facilities for TB case identification, treatment, follow up, referral, laboratory services, medicine and TB commodity supplies management and care and support. The activity covers selected private facilities in five administrative regions and two administrative cities.
U.S. Government Extends Commitment to Combat Tuberculosis in Ethiopia (February 18, 2015)
New Multi-Drug Resistant TB Facility Opens at Bishoftu Hospital (September 28, 2014)
Last updated: July 28, 2015